Response to Dekker, Stege, and Versteeg

Jeanne S Mandelblatt¹, Xingtao Zhou², Brent J Small³, Jaeil Ahn⁴, Wanting Zhai², Tim Ahles⁵, Martine Extermann⁶, Deena Graham⁷, Paul B Jacobsen⁸, Heather Jim⁹, Brenna C McDonald¹⁰, Sunita K Patel¹¹, James C Root^{12

13}, Andrew J Saykin¹⁴, Harvey Jay Cohen¹⁵, Judith E Carroll¹⁶

Affiliations

¹ Department of Oncology, Cancer Prevention and Control Program, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
² Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
³ School of Aging Studies, University of South Florida, and Health Outcome and Behavior Program and Biostatistics Resource Core, H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida, Tampa, FL, USA.
⁴ Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
⁵ Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
⁶ Department of Oncology, Moffitt Cancer Center, University of South Florida, Tampa, FL, USA.
⁷ John Theurer Cancer Center, Hackensack, NJ, USA.
⁸ Division of Cancer Control and Population Sciences, Healthcare Delivery Research Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
⁹ Department of Health Outcomes and Behavior, Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL, USA.
¹⁰ Department of Radiology and Imaging Sciences and the Melvin and Bren Simon Cancer Center, Center for Neuroimaging, Indiana University School of Medicine, Indianapolis, IN, USA.
¹¹ Departments of Population Sciences and Supportive Care Medicine, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
¹² Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
¹³ Departments of Psychiatry and Anesthesiology, Weill Medical College of Cornell University, New York, NY, USA.
¹⁴ Department of Radiology and Imaging Sciences and the Melvin and Bren Simon Cancer Center, Center for Neuroimaging , Indiana University School of Medicine, Indianapolis, IN, USA.
¹⁵ Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
¹⁶ UCLA Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Jane and Terry Semel Institute for Neuroscience and Human Behavior, Jonsson Comprehensive Cancer Center, and Cousins Center for Psychoneuroimmunology, Los Angeles, CA, USA.

PMID: 33823011
PMCID: PMC8486326
DOI: 10.1093/jnci/djab060

Comment

Response to Dekker, Stege, and Versteeg

Jeanne S Mandelblatt et al. J Natl Cancer Inst. 2021.

. 2021 Oct 1;113(10):1436-1437.

doi: 10.1093/jnci/djab060.

Authors

Affiliations

¹ Department of Oncology, Cancer Prevention and Control Program, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
² Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
³ School of Aging Studies, University of South Florida, and Health Outcome and Behavior Program and Biostatistics Resource Core, H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida, Tampa, FL, USA.
⁴ Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
⁵ Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
⁶ Department of Oncology, Moffitt Cancer Center, University of South Florida, Tampa, FL, USA.
⁷ John Theurer Cancer Center, Hackensack, NJ, USA.
⁸ Division of Cancer Control and Population Sciences, Healthcare Delivery Research Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
⁹ Department of Health Outcomes and Behavior, Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL, USA.
¹⁰ Department of Radiology and Imaging Sciences and the Melvin and Bren Simon Cancer Center, Center for Neuroimaging, Indiana University School of Medicine, Indianapolis, IN, USA.
¹¹ Departments of Population Sciences and Supportive Care Medicine, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
¹² Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
¹³ Departments of Psychiatry and Anesthesiology, Weill Medical College of Cornell University, New York, NY, USA.
¹⁴ Department of Radiology and Imaging Sciences and the Melvin and Bren Simon Cancer Center, Center for Neuroimaging , Indiana University School of Medicine, Indianapolis, IN, USA.
¹⁵ Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
¹⁶ UCLA Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, Jane and Terry Semel Institute for Neuroscience and Human Behavior, Jonsson Comprehensive Cancer Center, and Cousins Center for Psychoneuroimmunology, Los Angeles, CA, USA.

PMID: 33823011
PMCID: PMC8486326
DOI: 10.1093/jnci/djab060

No abstract available

PubMed Disclaimer

Comment in

RE: Deficit Accumulation Frailty Trajectories of Older Breast Cancer Survivors and Non-Cancer Controls: The Thinking and Living With Cancer Study.
Dekker J, Stege CAM, Versteeg KS. Dekker J, et al. J Natl Cancer Inst. 2021 Oct 1;113(10):1434-1435. doi: 10.1093/jnci/djab059. J Natl Cancer Inst. 2021. PMID: 33823005 Free PMC article. No abstract available.

Comment on

RE: Deficit Accumulation Frailty Trajectories of Older Breast Cancer Survivors and Non-Cancer Controls: The Thinking and Living With Cancer Study.
Dekker J, Stege CAM, Versteeg KS. Dekker J, et al. J Natl Cancer Inst. 2021 Oct 1;113(10):1434-1435. doi: 10.1093/jnci/djab059. J Natl Cancer Inst. 2021. PMID: 33823005 Free PMC article. No abstract available.

References

1. Howlader NNA, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, eds. SEER Cancer Statistics Review, 1975-2017. Bethesda, MD: National Cancer Institute; 2019.
1. Guida JL, Ahles TA, Belsky D, et al.Measuring aging and identifying aging phenotypes in cancer survivors. J Natl Cancer Inst. 2019;111(12):1245–1254. - PMC - PubMed
1. National Institutes of Health. Notice of Special Interest (NOSI): Understanding the effects of cancer and cancer treatment on aging trajectories and aging outcomes. NOT-CA-21-031. https://grants.nih.gov/grants/guide/notice-files/NOT-CA-21-031.html. Published 2021. Accessed March 19, 2021.
1. Rockwood K, Howlett SE.. Age-related deficit accumulation and the diseases of ageing. Mech Ageing Dev. 2019;180:107–116. - PubMed
1. Hurria A, Mohile S, Gajra A, et al.Validation of a prediction tool for chemotherapy toxicity in older adults with cancer. J Clin Oncol. 2016;34(20):2366–2371. - PMC - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Response to Dekker, Stege, and Versteeg

Affiliations

Response to Dekker, Stege, and Versteeg

Authors

Affiliations

Comment in

Comment on

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical